KLOTHO Therapeutics

San Diego, United States Founded: 2016 • Age: 10 yrs
Patent-pending klotho protein technology is developed for anti-aging applications.

About KLOTHO Therapeutics

KLOTHO Therapeutics is a Healthcare company based in San Diego (United States) founded in 2016. Patent-pending klotho protein technology is developed for anti-aging applications. KLOTHO Therapeutics has raised $10 million across 1 funding round from investors including Thynk Capital. KLOTHO Therapeutics offers products and services including Human Klotho Protein. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Reagents and Kits and Proteomics.

Company details

Klotho Therapeutics was founded in 2016 in San Diego, United States, within the biotechnology sector. Technology mimicking the human Klotho protein, a single-pass membrane protein, is developed to address aging-related conditions. Longevity is promoted, while onset of dementia, kidney disease, diabetes, and cancer is delayed through this approach. Operations focus on patent-pending innovations for therapeutic applications.

Key Metrics
  • Total Equity Funding
    $10M (USD)

    in 1 rounds

  • Latest Funding Round
    $10M (USD), Series A

    Nov 2017

  • Investors

Products & Services of KLOTHO Therapeutics

KLOTHO Therapeutics offers a comprehensive portfolio of products and services, including Human Klotho Protein.

Human Klotho Protein
Biotechnology Product

Patented protein that delays aging-related diseases like cognitive decline.

Apps and channels of KLOTHO Therapeutics

its YouTube channel Klotho Marketing has 61 subscribers and 3 videos.

Klotho Marketing
YouTube 61 subscribers 3 videos Business & Finance
Open channel

Videos from KLOTHO Therapeutics

The most watched videos on KLOTHO Therapeutics's YouTube channel, Klotho Marketing (61 subscribers). Click a video to play it here.

Klotho Therapeutics Introduction Video
1.4K views
Bill Ramage, TEDx Talks - Living Well Longer with Klotho
1K views
ASN Video
287 views

More on Klotho Marketing.

Funding Insights of KLOTHO Therapeutics

KLOTHO Therapeutics has successfully raised a total of $10M through 1 strategic funding round. The most recent funding activity was a Series A round of $10 million completed in November 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $10M
  • Total Rounds 1
  • Last Round Series A β€” $10M
  • First Round $10M

    (Nov 2017)

  • Investors Count 1

All 1 funding rounds of KLOTHO Therapeutics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Nov 2017$10MSeries A–Thynk Capital
–
Valuation history

1 investors in total: 1 institutional.

Investors in KLOTHO Therapeutics

KLOTHO Therapeutics has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Thynk Capital.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
Early-stage tech & life sciences focused VC firm funding companies in South Africa
thynkcapital.comSan Diego, United States
Premium access

Investor details for KLOTHO Therapeutics

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of KLOTHO Therapeutics

1 people are tracked at KLOTHO Therapeutics (1 in leadership).

NameRoleGroup
James Plante
Founder, Chief Executive Officer & ChairmanLeadership
Premium access

Complete people profiles for KLOTHO Therapeutics

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of KLOTHO Therapeutics

2 dated milestones of KLOTHO Therapeutics across 1 years, from founding to its latest funding, stage changes and deals.

  1. Founded KLOTHO Therapeutics is founded.
  2. Funding First funding round of $10.0M.

Web traffic of KLOTHO Therapeutics

The website of KLOTHO Therapeutics (klotho.com) receives about 3.4K visits a month.

  • Monthly visits
    3.4K

    ▲ 50.7% vs previous month

Similar websites

Websites whose visitors overlap most with KLOTHO Therapeutics. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
buckylabs.com
buckylabs.com
100%
#4,178,344–

Top companies in Life Sciences Platforms & Tools

3 companies that operate in the same segment as KLOTHO Therapeutics (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Medidata is recognized as a leading provider of SaaS solutions for clinical research.
1999New York, New York, United StatesUSD 41.5 M
AI-based solutions for health management are provided.
2015Dallas, Texas, United StatesUSD 2.8 B1,111
Real-world health data is provided for research and decisions.
2012Menlo Park, California, United StatesUSD 259.16 M
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Klotho Therapeutics

Premium access

Complete news archive for KLOTHO Therapeutics

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about KLOTHO Therapeutics

KLOTHO Therapeutics was founded in 2016 and raised its 1st funding round 1 year after it was founded.

KLOTHO Therapeutics is headquartered in San Diego, United States. It is registered at San Diego, California, United States.

KLOTHO Therapeutics is a funded company, having raised a total of $10M across 1 funding round to date. The company's 1st funding round was a Series A of $10M, raised on Nov 2017.

Klotho Therapeutics was founded in 2016 in San Diego, United States, within the biotechnology sector. Technology mimicking the human Klotho protein, a single-pass membrane protein, is developed to address aging-related conditions. Longevity is promoted, while onset of dementia, kidney disease, diabetes, and cancer is delayed through this approach. Operations focus on patent-pending innovations for therapeutic applications.

KLOTHO Therapeutics offers Human Klotho Protein.

KLOTHO Therapeutics has 1 investor. Key investors include Thynk Capital.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available